Comments on: Novartis Lines Up $3.2B Deal for Kidney Disease Drugs, But FTC Questions Loom

Comments on: Novartis Lines Up $3.2B Deal for Kidney Disease Drugs, But FTC Questions Loom https://medcitynews.com/2023/06/novartis-rare-kidney-disease-drugs-merger-acquisition-ftc/ Healthcare technology news, life science current events Tue, 13 Jun 2023 21:38:21 +0000 hourly 1 https://wordpress.org/?v=6.3.1